Prices delayed by at least 15 minutes | Print


MannKind Corp (MNKD)

Common Shares
Sell: $4.32|Buy: $4.33|Change: 0.23 (5.60%)

This share can be held in a Dealing accountISALifetime ISAJISASIPP

Company profile

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Address

30930 Russell Ranch Road
Suite 300
Westlake Village
CA
USA
91362


Telephone

+1 818 661-5000


Sector 

Healthcare


Previous key dates

NameKey Date
MannKind Corp Annual General Meeting for 20242024-05-24T10:00:00
MannKind Corp First Quarter Earnings Conference Call for 20242024-05-09T17:00:00
MannKind Corp First Quarter Earnings Results for 20242024-05-09T00:00:00
MannKind Oppenheimer 34th Annual Healthcare MedTech & Services 20242024-03-13T09:20:00
MannKind Corporation Leerink Partners Global Biopharma Conference 20242024-03-11T00:00:00
MannKind Corp Fourth Quarter Earnings Conference Call for 20232024-02-27T17:00:00
MannKind Corp Fourth Quarter Earnings Result for 20232024-02-27T00:00:00
MannKind Corp Annual Report for 20232024-02-27T00:00:00
42nd Annual J.P. Morgan Healthcare Conference2024-01-11T11:15:00
MannKind Investor Call 2024 – Royalty Sale Agreement2024-01-03T09:00:00
MannKind Corp Third Quarter Earnings Conference Call for 20232023-11-07T17:00:00
MannKind Corp Third Quarter Earnings Result for 20232023-11-07T00:00:00
2023 Cantor Global Healthcare Conference2023-09-27T11:30:00
Morgan Stanley 21st Annual Global Healthcare2023-09-13T08:10:00
H.C. Wainwright 25th Annual Global Investment Conference2023-09-11T08:30:00
MannKind Corp Second Quarter Earnings Conference Call for 20232023-08-07T17:00:00
MannKind Corp Second Quarter Earnings Result for 20232023-08-07T00:00:00
MannKind Corp Annual General Meeting for 20232023-05-25T10:00:00
2023 RBC Capital Markets Global Healthcare Conference2023-05-16T14:05:00
MannKind Corp First Quarter Earnings Conference Call for 20232023-05-09T17:00:00
MannKind Corp First Quarter Earnings Result for 20232023-05-09T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.